Botswana Pharmaceuticals & Healthcare Q2 2019
Botswana’s pharmaceutical market will continue on a positive growth trajectory. The government's commitment tocombatting the high prevalence of communicable diseases provides opportunities for drugmakers within the public healthcaresector. We note that the country’s demographic profile, particularly its low pensionable population, make it unfavourable forinnovative drugmakers, and growth will be driven mainly by generic drug imports.
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.Download eBook